Skip to main content
APhA DrugInfoLine
Sign in to your APhA membership account
Download a PDF of this month's content | Download a PDF of last month's content |Advanced Search
  • HOME
  • NEURO/PSYCH
    • Neurology
    • Psychiatry
  • HEART/LUNGS
    • Cardiology
    • Focus on Lipids Care
    • Focus on Anticoagulation Care
    • Respiratory
    • Focus on Asthma Care
  • GI/KIDNEYS
    • Gastroenterology
    • Nephrology
  • ENDOCRINE/RHEUM
    • Endocrinology
    • Focus on Diabetes Care
    • Rheumatology
  • ID/CANCERS
    • Infectious Diseases
    • Focus on HIV Care
    • Focus on Immunizations
    • Oncology
  • SELF-CARE
    • Alternative Medicines Corner
    • OTC Medicines Corner
  • PERSONALIZED CARE
    • Drug Interactions Corner
    • Pharmacogenomics Corner
  • Self-care
    Alternative Medicines C...
    May 10, 2016

    Cancer risk lower in women with higher vitamin D concentrations

    READ
  • Self-care
    OTC Medicines Corner...
    May 10, 2016

    Guidelines for use of aspirin to prevent cardiovascular disease, colorectal cancer

    READ
  • Personalized Care
    Pharmacogenomic...
    May 3, 2016

    Pharmacogenomics testing is cost effective

    READ
  • ID/Cancers
    Infectious Diseases...
    May 3, 2016

    Updated report on Clostridium difficile released

    READ
  • Endocrine/Rheum
    Rheumatology...
    April 26, 2016

    Tocilizumab may be good option as first-line therapy for...

    READ
  • ID/Cancers
    Focus on Immunizations...
    April 25, 2016

    Influenza vaccine appears safe in some children with egg allergy

    READ
  • Neuro/Psych
    Psychiatry...
    April 19, 2016

    Antipsychotics increase mortality risk in those with Parkinson...

    READ
  • Heart/Lungs
    Cardiology...
    April 19, 2016

    Lowering blood pressure too much in patients with diabetes may...

    READ
  • Self-care
    OTC Medicines Corner...
    April 11, 2016

    Acetaminophen may not be effective for influenza or influenza-...

    READ
  • Heart/Lungs
    Focus on Asthma Care...
    April 11, 2016

    Asthma may be a reason for zoster vaccination in adults

    READ
  • GI/Kidneys
    Nephrology...
    April 5, 2016

    Higher-target hemoglobin levels not associated with improved...

    READ
  • Read more about Cancer risk lower in women with higher vitamin D concentrations
  • Read more about Guidelines for use of aspirin to prevent cardiovascular disease, colorectal cancer
  • Read more about FDA approves first drug to treat hallucinations and delusions associated with Parkinson disease
  • Read more about FDA warns about new impulse-control problems associated with mental health drug
  • Read more about FDA approves brand name change for antidepressant drug Brintellix
  • Read more about Pharmacogenomics testing is cost effective
  • Read more about Updated report on Clostridium difficile released
  • Read more about FDA approves first generic Crestor
  • Read more about Indication expanded for treatment of COPD
  • Read more about Product may contain glass particulate matter

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Medication Monitor

NEW DRUG APPROVALS

  • May 3, 2016
    Pimavanserin
    (Nuplazid):
    FDA approves first drug to treat hallucinations and delusions associated with Parkinson disease
  • April 11, 2016
    Venetoclax
    (Venclexta):
    New drug treats chronic lymphocytic leukemia in patients with specific chromosomal abnormality
See more New Drug Approvals

SUPPLEMENTAL APPROVALS

  • April 30, 2016
    Rosuvastatin calcium
    (Crestor):
    FDA approves first generic Crestor
  • April 29, 2016
    Glycopyrrolate and formoterol fumarate
    (Bevespi Aerosphere):
    Indication expanded for treatment of COPD
See more Supplemental Approvals

ALERTS AND RECALLS

  • May 3, 2016
    Aripiprazole
    (Multiple trade names):
    FDA warns about new impulse-control problems associated with mental health drug
See more Alerts and Recalls

PRODUCT WITHDRAWALS

  • December 5, 2012
    Ondansetron
    (Zofran):
    High-dose removed from the market
See more Product withdrawals


                                

Editor's Picks

  • Cancer risk lower in women with higher vitamin D...
  • Guidelines for use of aspirin to prevent...
  • Pharmacogenomics testing is cost effective
  • Updated report on Clostridium difficile released
  • Tocilizumab may be good option as first-line...

Popular Articles

  • New cholesterol guideline: LDL goals take...
  • Framingham gone: New guidelines redefine CVD...
  • Conservative management strategy preferred in low...
  • Fodder for pharmacists: New Chest guidelines...
  • Warfarin interactions: Some expected, some not

Popular Sections

  • Alerts and Recalls
  • Supplemental Approvals
  • New Drug Approvals
  • Cardiology
  • Alternative Medicines Corner

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

More info

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.

  • Contact Us
  • Section Advisors
  • Terms of Use
  • Privacy Policy